The Department of Biomedicine at the University of Basel is seeking a full-time Postdoctoral Researcher to join the Blood Cancer Biology and Immunotherapy Group led by Professor Petya Apostolova. Funded by an ERC Starting Grant project titled 'LIFE', the position focuses on investigating how cellular metabolism influences leukemia persistence, immune evasion, and anti-leukemia immunity. Key responsibilities include designing and conducting mechanistic in vivo animal studies, establishing experimental methodologies, analyzing multi-omics data, and mentoring PhD and MSc students. Applicants must hold a PhD in cancer biology, immunology, molecular biology, or a related field, alongside substantial practical experience in mouse tumor models, spectral flow cytometry, and molecular biology. The initial appointment is for one year starting February 1, 2027, with potential extension. Applications are submitted online via the university portal.
| Department | Department of Biomedicine (DBM) |
| Position Type | Postdoc |
| Discipline | Cancer Biology / Immunology / Hematology |
| Research Area | Leukemia Immunology and Metabolism |
| Degree Required | PhD |
| Experience | Substantial practical experience with in vivo mouse tumor models, preferably involving hematological cancers, and extensive hands-on experience with spectral flow cytometry and molecular biology. |
| Funding | European Research Council (ERC) Starting Grant project LIFE |
| Contract Duration | One year, with the possibility of extension and a long-term perspective |
| Language | English |
| Required Documents | Curriculum Vitae (CV) including publication list, Most important original research publication, Statement of research experience, scientific interests, and motivation, Contact details for two to three references |
| Employer Address | Basel, Switzerland |
Funded by an ERC Starting Grant project named LIFE, the research investigates how cellular metabolism impacts leukemia persistence, immune evasion, and anti-leukemia immunity. The project explores metabolic adaptations under therapeutic pressure and aims to target bioactive lipids to improve outcomes in allogeneic hematopoietic stem cell transplantation.
Researchers holding a PhD in cancer biology, immunology, molecular biology, hematology, or a related discipline with strong experience in in vivo mouse tumor models, spectral flow cytometry, and molecular biology. Candidates should demonstrate an interest in taking ownership of a project focused on leukemia metabolism and immunology.
The Department of Biomedicine (DBM) is a joint venture between the University of Basel and the University Hospitals Basel, encompassing over 67 research groups and more than 800 employees across six locations in Basel.
The application deadline is not specified in the job advertisement.
The anticipated start date is February 1, 2027, or another date agreed upon by mutual agreement.
Applicants must hold a PhD or equivalent degree in cancer biology, immunology, molecular biology, hematology, or a related discipline.
The initial appointment is for one year, with the possibility of extension and a long-term perspective.
This listing is summarised from the official advertisement. Always confirm the details, including the closing date, on the employer's own site before applying.
UpperCareers
Search 420+ open postdoc, PhD, assistant professor positions
Filter by field, country and institution — every vacancy links straight to the employer.
Browse all positions →